SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0000950103-24-003853
Filing Date
2024-03-14
Accepted
2024-03-14 16:43:35
Documents
11

Document Format Files

Seq Description Document Type Size
1 FORM F-3 dp208309_f3.htm F-3 291262
2 EXHIBIT 4.2 dp208309_ex0402.htm EX-4.2 313797
3 EXHIBIT 4.3 dp208309_ex0403.htm EX-4.3 329326
4 EXHIBIT 5.1 dp208309_ex0501.htm EX-5.1 36544
5 EXHIBIT 5.2 dp208309_ex0502.htm EX-5.2 21225
6 EXHIBIT 23.1 dp208309_ex2301.htm EX-23.1 2089
7 EXHIBIT 107 dp208309_exfilingfees.htm EX-FILING FEES 55594
8 GRAPHIC image_001.jpg GRAPHIC 8419
9 GRAPHIC image_002.jpg GRAPHIC 1543
10 GRAPHIC image_003.jpg GRAPHIC 1771
11 GRAPHIC ex0501logo.jpg GRAPHIC 8570
  Complete submission text file 0000950103-24-003853.txt   1079374
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-277940 | Film No.: 24750886
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)